China Regenerative Medicine International Limited (8158) Announces Delay in Circular Dispatch

Bulletin Express

2025/11/21

China Regenerative Medicine International Limited (Stock Code: 8158) announced that the dispatch of a circular relating to its previously disclosed major transactions and breach of GEM Listing Rules will be delayed. The circular was initially scheduled for dispatch on or before 21 November 2025 and pertains to the Outstanding Payment Agreement, the Membership Transfer Agreements, and other related details.

The announcement specifies that additional time is needed to finalize information to be included in the circular. The company is therefore applying to the Stock Exchange for a waiver from strict compliance with the relevant GEM Listing Rules. It is currently expected that the dispatch date of the circular will be postponed to a date on or before 31 December 2025.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1105185288"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1105185288\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1105185288?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-21 20:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105185288","market":"hk","top_or_hot":-1,"title":"China Regenerative Medicine International Limited (8158) Announces Delay in Circular Dispatch","media":"Bulletin Express","content":"<p>China Regenerative Medicine International Limited (Stock Code: 8158) announced that the dispatch of a circular relating to its previously disclosed major transactions and breach of GEM Listing Rules will be delayed. The circular was initially scheduled for dispatch on or before 21 November 2025 and pertains to the Outstanding Payment Agreement, the Membership Transfer Agreements, and other related details.</p>\n<p>The announcement specifies that additional time is needed to finalize information to be included in the circular. The company is therefore applying to the Stock Exchange for a waiver from strict compliance with the relevant GEM Listing Rules. It is currently expected that the dispatch date of the circular will be postponed to a date on or before 31 December 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Regenerative Medicine International Limited (8158) Announces Delay in Circular Dispatch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Regenerative Medicine International Limited (8158) Announces Delay in Circular Dispatch\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2025-11-21 20:14</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>China Regenerative Medicine International Limited (Stock Code: 8158) announced that the dispatch of a circular relating to its previously disclosed major transactions and breach of GEM Listing Rules will be delayed. The circular was initially scheduled for dispatch on or before 21 November 2025 and pertains to the Outstanding Payment Agreement, the Membership Transfer Agreements, and other related details.</p>\n<p>The announcement specifies that additional time is needed to finalize information to be included in the circular. The company is therefore applying to the Stock Exchange for a waiver from strict compliance with the relevant GEM Listing Rules. It is currently expected that the dispatch date of the circular will be postponed to a date on or before 31 December 2025.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"08158","symbol_name":"中國再生醫學","start_time":0,"source_url":"","article_id":"1105185288","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105185288","pubTimestamp":1763727254,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Regenerative Medicine International Limited (Stock Code: 8158) announced that the dispatch of a circular relating to its previously disclosed major transactions and breach of GEM Listing Rules...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"08158":"中国再生医学"},"translate_title":"中国再生医学国际有限公司(8158)公布延迟寄发通函","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08158":1},"content_text":"China Regenerative Medicine International Limited (Stock Code: 8158) announced that the dispatch of a circular relating to its previously disclosed major transactions and breach of GEM Listing Rules will be delayed. The circular was initially scheduled for dispatch on or before 21 November 2025 and pertains to the Outstanding Payment Agreement, the Membership Transfer Agreements, and other related details.\nThe announcement specifies that additional time is needed to finalize information to be included in the circular. The company is therefore applying to the Stock Exchange for a waiver from strict compliance with the relevant GEM Listing Rules. It is currently expected that the dispatch date of the circular will be postponed to a date on or before 31 December 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}